Cargando…

Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer

BACKGROUND: The aim of this study was to investigate the clinical value of liquid biopsy as a primary source for variant analysis in lung cancer. In addition, we sought to characterize liquid biopsy variants and to correlate mutational load to clinical data. METHODS: Circulating cell-free DNA was ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qvick, Alvida, Stenmark, Bianca, Carlsson, Jessica, Isaksson, Johan, Karlsson, Christina, Helenius, Gisela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254966/ https://www.ncbi.nlm.nih.gov/pubmed/34217228 http://dx.doi.org/10.1186/s10020-021-00331-1

Ejemplares similares

Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?
por: Qvick, Alvida, et al.
Publicado: (2017)

Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma
por: Falck, Eva, et al.
Publicado: (2010)

Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate
por: Carlsson, Jessica, et al.
Publicado: (2013)

Liquid biopsy in lung cancer management
por: Irofei Zamfir, Maria-Anca, et al.
Publicado: (2022)

Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer
por: Li, Peilong, et al.
Publicado: (2022)

A miRNA expression signature that separates between normal and malignant prostate tissues
por: Carlsson, Jessica, et al.
Publicado: (2011)

The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction
por: Li, Shiyu, et al.
Publicado: (2020)

Liquid Biopsies in Cancer Diagnosis, Monitoring and Prognosis
por: Ulivi, Paola, et al.
Publicado: (2022)

The liquid biopsy in lung cancer
por: Ansari, Junaid, et al.
Publicado: (2016)

Liquid Biopsies in Lung Cancer
por: Kemper, Marcel, et al.
Publicado: (2023)

Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy
por: Chen, Kezhong, et al.
Publicado: (2021)

Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis
por: Wu, Jicheng, et al.
Publicado: (2020)

Liquid biopsy for lung cancer immunotherapy
por: Cai, Liang-Liang, et al.
Publicado: (2019)

Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer
por: Hirahata, Tetsuyuki, et al.
Publicado: (2022)

Liquid biopsies in epilepsy: biomarkers for etiology, diagnosis, prognosis, and therapeutics
por: Whitlock, Jordan H., et al.
Publicado: (2021)

Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer
por: Rzhevskiy, Alexey S., et al.
Publicado: (2022)

Liquid biopsies come of age in lung cancer
por: Christopoulos, Petros
Publicado: (2022)

Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
por: Nunes, Sandra P., et al.
Publicado: (2019)

Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
por: Zhou, Hui, et al.
Publicado: (2022)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021)

The Role of Liquid Biopsy Analytes in Diagnosis, Treatment and Prognosis of Colorectal Cancer
por: He, JinHua, et al.
Publicado: (2022)

The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 Astrocytoma
por: Halawa, Taher, et al.
Publicado: (2023)

Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis
por: Souza, Vanessa G. P., et al.
Publicado: (2023)

Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients
por: de Fraipont, Florence, et al.
Publicado: (2019)

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring
por: Li, Wen, et al.
Publicado: (2022)

Liquid Biopsy in Non-Small Cell Lung Cancer
por: Molina-Vila, Miguel A., et al.
Publicado: (2016)

A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
por: Kidd, Mark, et al.
Publicado: (2017)

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
por: Freitas, Cláudia, et al.
Publicado: (2021)

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
por: Mattsson, Johanna S. M., et al.
Publicado: (2016)

Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16-Positive Vaginal and Vulvar Carcinomas
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2014)

HPV-based screening for cervical cancer among women 55-59 years of age
por: Bergengren, Lovisa, et al.
Publicado: (2019)

KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
por: Nacchio, Mariantonia, et al.
Publicado: (2020)

Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors
por: Aghamir, Seyed Mohammad Kazem, et al.
Publicado: (2020)

Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

Liquid biopsy in lymphoma: Is it primed for clinical translation?
por: Poynton, Edward, et al.
Publicado: (2021)

Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
por: Hench, Ivana Bratić, et al.
Publicado: (2018)

Liquid biopsy genotyping in lung cancer: ready for clinical utility?
por: Huang, Wei-Lun, et al.
Publicado: (2017)

ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients
por: Hofman, Paul
Publicado: (2017)

Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer
por: Pesta, Martin, et al.
Publicado: (2022)

Liquid biopsy in lymphoma
por: Rossi, Davide, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dn8d538rmt809nuf8d99pr5cbh